Cargando…
Tetrathiomolybdate sensitizes ovarian cancer cells to anticancer drugs doxorubicin, fenretinide, 5-fluorouracil and mitomycin C
BACKGROUND: Our recent study showed that tetrathiomolybdate (TM), a drug to treat copper overload disorders, can sensitize drug-resistant endometrial cancer cells to reactive oxygen species (ROS)-generating anticancer drug doxorubicin. To expand these findings in the present study we explore TM effi...
Autores principales: | Kim, Kyu Kwang, Lange, Thilo S, Singh, Rakesh K, Brard, Laurent, Moore, Richard G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3353246/ https://www.ncbi.nlm.nih.gov/pubmed/22502731 http://dx.doi.org/10.1186/1471-2407-12-147 |
Ejemplares similares
-
Lipophilic aroylhydrazone chelator HNTMB and its multiple effects on ovarian cancer cells
por: Kim, Kyu Kwang, et al.
Publicado: (2010) -
Iron(III)-Salophene: An Organometallic Compound with Selective Cytotoxic and Anti-Proliferative Properties in Platinum-Resistant Ovarian Cancer Cells
por: Lange, Thilo S., et al.
Publicado: (2008) -
Correction: Iron(III)-Salophene: An Organometallic Compound with Selective Cytotoxic and Anti-Proliferative Properties in Platinum-Resistant Ovarian Cancer Cells
por: Lange, Thilo S., et al.
Publicado: (2008) -
Tetrathiomolybdate inhibits mitochondrial complex IV and mediates degradation of hypoxia-inducible factor-1α in cancer cells
por: Kwang Kim, Kyu, et al.
Publicado: (2015) -
Organometallic Iron(III)-Salophene Exerts Cytotoxic Properties in Neuroblastoma Cells via MAPK Activation and ROS Generation
por: Kim, Kyu Kwang, et al.
Publicado: (2011)